top of page
external-file_edited (1)_edited_edited_edited_edited.png

Hello.

Welcome to BioFocus. 
Explore the latest updates from the life science industry.

Popular Content.

Breakthrough "Armoured" CAR T-Cell Therapy Shows Promising Results in Tough-to-Treat Lymphomas

In a phase 1 study, 81% of patients responded to IL18-boosted therapy, with over half achieving complete remission.

 Featured Articles. 

7-format11240.jpg
BIOTECH

One Million New Species Discovered

7-format11240.jpg
BIOTECH

SolasCure Receives FDA Fast Track Designation for Aurase Wound Gel in Treatment of Calciphylaxis Ulcers

7-format11240.jpg
PHARMA

Women’s Health Therapeutics Market Enters Transformative Growth Phase

7-format11240.jpg
BIOTECH

Using Jumping Genes for Safer, More Accurate DNA Editing

7-format11240.jpg
PHARMA

Compass Pathways' Phase 3 Psilocybin Readout Raises Efficacy Questions Despite Meeting Primary Endpoint

7-format11240.jpg
HEALTH

The Applications of Wearable Biosensors

7-format11240.jpg
SPONSORED

Accelerating cell therapy development and manufacturing

7-format11240.jpg
BIOPROCESSING

Fujifilm Rebrands Life Sciences Units to Strengthen Unified Market Presence Under ‘Partners for Life’ Strategy

7-format11240.jpg
SPONSORED

Preparing your cell culture workflow to scale for success

 Latest News. 

11th July, 2025

01.

SPT Labtech and Semarion Join Forces to Advance Automated Cell-Based Assays

SPT Labtech and Semarion have partnered to create flexible, automated, and miniaturized workflows for advanced cell-based assays.

6th July, 2025

02.

Shift Bioscience Unveils Improved Virtual Cell Model Ranking to Accelerate Gene Target Discovery

Shift Bioscience has unveiled an improved ranking system for virtual cell models, enhancing gene target discovery through better performance metrics in rejuvenation research.

4th July, 2025

03.

ProBio Opens Cell and Gene Therapy Center of Excellence in New Jersey.

The 128,000-sq-ft GMP cell and gene therapy facility in New Jersey, expands the CDMOs U.S. capabilities in plasmid, AAV, and LVV manufacturing.

3rd July, 2025

04.

Optibrium Joins Forces with TalTech to Develop Sustainable AI-Driven Drug Discovery

EU-funded PhD research program focuses on improving methods for predicting drug metabolism.

Editor's Selects.

Weighing the Cost of Semaglutide

Essential Strategies for Scaling Up Biologics

Biotechnology in Agriculture - Feeding the World’s Growing Population

Top Trends in Pharmaceutical Sustainability for 2025

Stay up-to-date. Connect with BioFocus on LinkedIn or subscribe to our mailing list.

bottom of page